Publications citing Assaypro: Human Apolipoprotein A-I (Apo A1) ELISA Kit... (59 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Role of DJ-1 and Apo A1 as biomarkers in Parkinson's disease: an observational case-control study
Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and...
Phytosterols and omega 3 supplementation exert novel regulatory effects on metabolic and inflammatory pathways: a proteomic study
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
High performance lipoprotein profiling for cardiovascular risk assessment
Intervenciones nutricionales en la prevenci�n cardiovascular y efectos de los factores de riesgo en el tejido adiposo
Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke
Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function
Nutritional interventions in cardiovascular prevention and effects of risk factors on adipose tissue
Leptin and Tumor necrosis factor alpha in breast
Serum Syndecan-1 and Apolipoprotein A1 in patients with chronic HCV infection
Diagnostic value of apolipoprotein A1 in neonatal sepsis
Role of DJ-1 and Apo A1 as biomarkers in Parkinson?s disease: an observational case-control study
Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection
Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria
Assessment of the relationship between markers of inflammation, adipokines and lipid metabolism parameters in overweight and obese individuals.
Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity
A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
Glycoproteome of human apolipoprotein AI: N-and O-glycosylated forms are increased in patients with acute myocardial infarction
The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease
Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients
The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents
Artificial neural network-based serum biomarkers analysis improves sensitivity in the diagnosis of lung cancer
Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach
Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD
Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels
High Performance Lipoprotein Profiling for Cardiovascular Risk Assessment
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]
Identification of haptoglobin and apolipoprotein AI as biomarkers for high altitude pulmonary edema
High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease
A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection
Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study
Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function
Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus
Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection
Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma
The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols.
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA [S]
Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction
Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children
Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels
Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics
Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD
The Effects of Rope Training on Lymphocyte ABCA1 Expression, Plasma ApoA-I and HDL-c in Boy Adolescents
Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach *
Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.
Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level
Plasma profiles in active systemic juvenile idiopathic arthritis: biomarkers and biological implications